Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | APO | BAM |
|---|---|---|
| Price | $120.47 | $44.35 |
| Change today | ▼ 3.13% | ▼ 2.02% |
| Market cap | $71.14B | $70.83B |
| Return, 3 months | -1.3% | -0.3% |
| Return, year to date | -15.7% | -10.9% |
| Return, 1 year | -10.7% | -19.7% |
| P/E (TTM) | 42.9 | 25.8 |
| P/B | 3.6 | 9.4 |
| P/E percentile vs own 5y | 88th | 31st |
| Dividend yield | 1.74% | 4.24% |
| Revenue growth (YoY, latest qtr) | +63.7% | +4.1% |
| Net profit growth (YoY) | +148.1% | +100.7% |
| Gross margin | 95.4% | 69.5% |
| Operating margin | 24.9% | 78.4% |
| Net margin | 1.3% | 58.2% |
| Return on equity | 2.5% | 35.1% |
| Analyst target vs. price | +27.2% | +30.5% |
| Analyst buy share | 83% | 50% |
| RSI (14) | 42 | 33 |
| 30-day volatility | 28.4% | 26.0% |
| Max drawdown, 1 year | -34.0% | -27.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.